Tamar. Aprahamian, et.al., Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease., The Journal of experimental medicine, 2004, 199

http://rdf.ncbi.nlm.nih.gov/pubmed/15096538

Tamar. Aprahamian, et.al., Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease., The Journal of experimental medicine, 2004, 199

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased circulating cholesterol level_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0005178B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• increased susceptibility to atherosclerosis_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0005339B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• increased autoantibody level_Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0003725B6C3FaslgldFaslgldFaslgldFaslgld
• increased IgG level_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0002493B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• enlarged spleen_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0000691B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• enlarged lymph nodes_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0000702B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• abnormal lymph node morphology_Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0002339B6C3FaslgldFaslgldFaslgldFaslgld
• increased T cell number_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0005015B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• abnormal lymph node morphology_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0002339B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• increased circulating triglyceride level_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0001552B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• impaired macrophage phagocytosis_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0001798B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• increased urine protein level_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0002962B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• increased spleen weight_Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0004952B6C3FaslgldFaslgldFaslgldFaslgld
• increased circulating cholesterol level_Apoe<tm1Unc>/Apoe<tm1Unc>
  http://metadb.riken.jp/0005178B6129P2Apoetm1UncJApoetm1UncApoetm1UncApoetm1Unc
• increased autoantibody level_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0003725B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• vascular inflammation_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0001863B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• increased circulating triglyceride level_Apoe<tm1Unc>/Apoe<tm1Unc>
  http://metadb.riken.jp/0001552B6129P2Apoetm1UncJApoetm1UncApoetm1UncApoetm1Unc
• increased anti-nuclear antigen antibody level_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0004794B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• enlarged lymph nodes_Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0000702B6C3FaslgldFaslgldFaslgldFaslgld
• abnormal renal glomerulus morphology_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0005325B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• decreased circulating HDL cholesterol level_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0000186B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• impaired macrophage phagocytosis_Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0001798B6C3FaslgldFaslgldFaslgldFaslgld
• increased apoptosis_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0006042B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• enlarged spleen_Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0000691B6C3FaslgldFaslgldFaslgldFaslgld
• increased circulating LDL cholesterol level_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0000182B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• atherosclerotic lesions_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0005338B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• increased anti-nuclear antigen antibody level_Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0004794B6C3FaslgldFaslgldFaslgldFaslgld
• vascular inflammation_Apoe<tm1Unc>/Apoe<tm1Unc>
  http://metadb.riken.jp/0001863B6129P2Apoetm1UncJApoetm1UncApoetm1UncApoetm1Unc
• increased circulating VLDL cholesterol level_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0005145B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• increased apoptosis_Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0006042B6C3FaslgldFaslgldFaslgldFaslgld
• decreased circulating HDL cholesterol level_Apoe<tm1Unc>/Apoe<tm1Unc>
  http://metadb.riken.jp/0000186B6129P2Apoetm1UncJApoetm1UncApoetm1UncApoetm1Unc
• increased circulating LDL cholesterol level_Apoe<tm1Unc>/Apoe<tm1Unc>
  http://metadb.riken.jp/0000182B6129P2Apoetm1UncJApoetm1UncApoetm1UncApoetm1Unc
• increased circulating VLDL cholesterol level_Apoe<tm1Unc>/Apoe<tm1Unc>
  http://metadb.riken.jp/0005145B6129P2Apoetm1UncJApoetm1UncApoetm1UncApoetm1Unc
• increased spleen weight_Apoe<tm1Unc>/Apoe<tm1Unc>,Fasl<gld>/Fasl<gld>
  http://metadb.riken.jp/0004952B6CgFaslgldApoetm1UncApoetm1UncApoetm1UncFaslgldFaslgldFaslgldApoetm1Unc
• atherosclerotic lesions_Apoe<tm1Unc>/Apoe<tm1Unc>
  http://metadb.riken.jp/0005338B6129P2Apoetm1UncJApoetm1UncApoetm1UncApoetm1Unc